At different stages of our lives, the body has different nutritional needs – and this is reflected in the Lifetime range of premium customized omega-3 solutions from Napro Pharma, a Cognis subsidiary that specializes in the manufacture of marine omega-3 oils. For customers aiming to market condition-specific formulations, it offers high-quality marine omega-3 oils characterized by their high purity and superior sensory profile. They are available in various delivery forms such as liquids or soft gel capsules, and are tailor-made to meet individual requirements of manufacturers focused on European markets.

The Lifetime concept comprises ready-to-market solutions for five different consumer groups. By offering omega-3 products with various ratios of the long-chain fatty acids EPA and DHA and concentrates up to 60 percent, Napro Pharma enables its customers to respond to the differing health and well-being demands of consumers at different stages of their lives. The five concept platforms are:

Each platform includes tailor-made solutions specifically targeted at the lifestyles of the different consumer groups, either as single omega-3 formulations or in combination with other health-enhancing ingredients.

Omevital™ Ultra – high purity and a superior sensory profile

Lifetime omega-3 solutions are based on the premium-quality Omevital™ Ultra range from Napro Pharma. Omevital™ Ultra marine oils have a superior sensory profile, with no fishy taste or odor and no reflux after intake (“fish oil repeat”). It is available in ethyl ester and triglyceride forms, and can be supplied in various delivery forms, such as bottled liquids or soft gel capsules. The formulations are tailor-made to specific customer needs and can also be flavored or blended with other ingredients. All these products are made using fish from sustainable sources from unpolluted seas and fully comply with the GMP standard.

Comments Petra Mueller, Global Product Line Manager Omega-3: “Lifetime is an innovative range that enables manufacturers focused on the European markets to systematically develop value-added concepts that will appeal to consumers of all ages. While our customized solutions are by definition extremely varied in nature, all of them are based on the proven quality of our premium omega-3 fatty acids of marine origin.”

Wenche U. Gabor, Sales Director Finished Products, explains: “There is an increasing demand for omega-3 solutions provided as finished products in various delivery forms. Lifetime is our response to this important market trend and reflects our goal to enable our customers to benefit from it.”

Note

The Lifetime range will be showcased at this year’s Vitafoods (Geneva; May 6-8, 2008) at Napro Pharma’s Stand 762.

About Napro Pharma / Cognis Nutrition & Health
Napro Pharma is a Norwegian manufacturer of high quality marine oils for the nutrition industry. Following the acquisition in 2006 by the Cognis Group, Napro Pharma now forms part of the Nutrition & Health strategic business unit. Cognis Nutrition & Health offers a wide range of high-performance natural-source ingredients to help manufacturers of consumer goods achieve success by meeting these demands. The portfolio ranges from plant sterols and plant extracts to mixed carotenoids and products for active body composition management. In 2007, Cognis Nutrition & Health recorded sales of 331 million euros.

About Cognis
Cognis is a worldwide supplier of innovative specialty chemicals and nutritional ingredients, with a particular focus on the areas of wellness and sustainability. The company employs about 7,600 people, and it operates production sites and service centers in 30 countries. Cognis has dedicated its activities to a high level of sustainability and delivers natural source raw materials and ingredients for food, nutrition and healthcare markets, and the cosmetics, detergents and cleaners industries. Another main focus is on products for a number of other industries, such as coatings and inks, lubricants, as well as agriculture and mining. The subsidiary Pulcra Chemicals offers specialized chemical products and process expertise to customers in the fiber, textile, and leather industries. Cognis also holds a 50-percent stake in the joint venture Cognis Oleochemicals, one of the world’s leading manufacturers of oleochemicals.

Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and SV Life Sciences. In 2007, Cognis recorded sales of about 3.52 billion euros and an Adjusted EBITDA (operating result) of 410 million euros.

Contact
Wenche U. Gabor, Sales Director Finished Products
Napro Pharma AS
Phone: +47-7140-4224
Email: [email protected]
Internet: www.napro-pharma.no

Viola Stahl, Communications Manager
Cognis GmbH
Phone: +49-2173-4995-221
Email: [email protected]
Internet: www.cognis.com